HealthLink Europe Provides Compass to Companies Looking to Go Overseas
HealthLink Europe help medical device and pharmaceutical manufacturers enter the European market by offering a full range of distribution-related services.
Month: February 2010
Pressure BioSciences Aims for Improved Sample Preparation
Pressure BioSciences seeks to improve sample yield with its novel technology platform, known as pressure cycling technology (PCT).
For Advaxis, Bacteria Help More Than They Hurt
The idea of using harmful bacteria to treat disease might strike many as an odd concept.
CytRx Puts Its Cancer Pipeline to the Test
All told, the Los Angeles-based company could have six to eight trials running simultaneously in the coming months.
Quintessence Biosciences’ Novel Approach to Cancer Therapy
Quintessence Biosciences is a biopharmaceutical company specializing in the development of novel protein-based therapeutics to fight cancer.
Register Now to Attend IN3 West
Discover the latest medtech innovations at this year’s IN3 West conference, which takes place March 3-5 at the Venetian Resort-Hotel-Casino in Las Vegas.
Vivostat’s Technology Turns Blood Into Surgical Glue
Vivostat is a Danish company that uses the patient’s blood to create a personalized surgical glue (fibrin sealant) that can be used for surgical procedures and the treatment of diabetic ulcers.
Chembio Diagnostics Tackles Infectious Diseases with Rapid-Diagnostic Platform
Chembio Diagnostics specializes in the development of advanced diagnostic tests for infectious diseases such as HIV and syphilis.
Oculus Looks Beyond Wound Care Market
Petaluma, Calif.-based Oculus Innovative Sciences specializes in the development of products to treat and prevent infections in wounds.
Urovalve at the 2010 OneMedForum
Harvey Homan, President and CEO of Urovalve, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.